Phio PharmaceuticalsPHIO
13F holders, Q1 2024 (March 31)10holders
$0.71avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Phio Pharmaceuticals Corp. (PHIO) in their 13F filings. The largest holders were Virtu Financial LLC ($21K), Cetera Investment Advisers ($21K) and Bank of Montreal ($17K).
- Company
- Phio Pharmaceuticals Corp.
- CUSIP
- 71880W402
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $923 |
| Exits | 5 | $291K |
Ownership 10 holders
| Virtu Financial LLC | 0.00% | Add +62.3% | 30,912 | $21K |
| Cetera Investment Advisers | 0.00% | Add +79.8% | 30,416 | $21K |
| Bank of Montreal | 0.00% | No change | 20,000 | $17K |
| Vanguard Group Inc. | 0.00% | No change | 24,380 | $17K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 23,486 | $16K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 14,233 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.3% | 5,697 | $4K |
| UBS Group AG | 0.00% | New | 1,358 | $923 |
| Wells Fargo & Company | 0.00% | No change | 19 | $13 |
| BlackRock Inc. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is PHIO's weight in each manager's 13F, not the share of Phio Pharmaceuticals Corp. the manager owns.